Childhood CancerNCT00579293
Development of a Computer Assisted Survivor Screening For Adult Survivors of Childhood Cancer
An observational study of Childhood Cancer, run by Memorial Sloan Kettering Cancer Center at 1 site in United States.
Trial summary
This study will compare two ways of having people respond to a questionnaire about health and emotional well-being: on a computer and with paper and pencil. We will see how long it takes using both methods. We will also ask you how you feel about using a computer to answer the questions. Read more about this study
- Who is it for?
- Ages 18 to 49 years
- Conditions the study is for
- Childhood Cancer
- How many people
- 100 participants
- Where
- 1 siteUnited States
- Study dates
- Aug 2004to Jul 2008
- Phase
- Observational
- Are there results?
- None posted in the registry
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 18 to 49 years
- All sexes
- No healthy volunteers
- Adult
Study population: adult survivors of childhood cancer
Who may be able to join
- Currently at least 18 years of age and not older than 49 years of age
- Diagnosed with first malignancy before the age of 22
- Completed all cancer treatment at least three years prior
- Able to complete the survey instruments in English
- Scheduled for a routine off-treatment follow-up oncology appointment
- Currently disease-free and not receiving any cancer treatment
Who cannot join
- History of a central nervous system tumor
- A sensory or cognitive impairment that would interfere with completion of the survey
- Currently undergoing treatment by a psychiatrist or psychologist (ie., currently receiving psychotherapy and/or psychotropic medications, as per self-report)
Trial locations and contacts
1 site in 1 country.
United States1 site
Memorial Sloan-Kettering Cancer Center
New York, New York, 10065
About this study
This study will compare two ways of having people respond to a questionnaire about health and emotional well-being: on a computer and with paper and pencil. We will see how long it takes using both methods. We will also ask you how you feel about using a computer to answer the questions.
Read the detailed description
To determine feasibility of using the Computer Assisted Survivor Screening (CASS) as a routine screening measure for the survivor population. Specifically, to determine patient acceptance, time to completion, and burden associated with the CASS. To examine the potential utility of the CASS as a routine screening measure in the survivor population. To validate the CASS against the SCL-90-R screening measure. Calculate the sensitivity,specificity, positive and negative predictive values, diagnostic agreement and ROC curve of the CASS compared to the SCL-90. Determine the optimal cut-off scores to optimize agreement between the CASS and the SCL-90.
- Conditions
- Childhood Cancer
- Keywords
- adult survivor of childhood cancer, computer assisted screening of survivors (CASS)
- Medical subject headings
- Neoplasms
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted24 Dec 2007 (estimated)
- Study startAug 2004
- Primary completionJul 2008
- Study completionJul 2008
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Other trials for Childhood CancerStudies of the same condition, open and under way.
- More trials run by Memorial Sloan Kettering Cancer CenterThe sponsor's other registered studies.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Observational
- Observational model
- Case only
- Time perspective
- Prospective
- Enrolment
- 100 participants (estimated)
Sponsor and investigators
- Lead sponsor
- Memorial Sloan Kettering Cancer Center
- Sponsor type
- University, hospital or other
- Investigators
- Jennifer Ford, PhD, Principal investigator, Memorial Sloan Kettering Cancer Center
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT00579293
- Sponsor's protocol ID
- 04-098
- Status last verified
- Jul 2008
- First submitted
- 20 Dec 2007
- Last updated
- 28 Jul 2008
- Results posted
- No
Study at a glance
From the registry record, last updated by the sponsor on 28 Jul 2008. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- Development of a Computer Assisted Survivor Screening For Adult Survivors of Childhood Cancer
- ClinicalTrials.gov ID
- NCT00579293
- Acronym / sponsor ID
- 04-098
- Conditions
- Childhood Cancer
- Keywords
- adult survivor of childhood cancer, computer assisted screening of survivors (CASS)
- Study type
- Observational
- Recruitment status
- Completed
- Enrolment
- 100 participants (estimated)
- Lead sponsor
- Memorial Sloan Kettering Cancer CenterUniversity, hospital or other
- Study start
- Aug 2004
- Primary completion
- Jul 2008 (actual)
- Study completion
- Jul 2008 (actual)
- First posted
- 24 Dec 2007 (estimated)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
This study will compare two ways of having people respond to a questionnaire about health and emotional well-being: on a computer and with paper and pencil. We will see how long it takes using both methods. We will also ask you how you feel about using a computer to answer the questions.
Detailed description
To determine feasibility of using the Computer Assisted Survivor Screening (CASS) as a routine screening measure for the survivor population. Specifically, to determine patient acceptance, time to completion, and burden associated with the CASS. To examine the potential utility of the CASS as a routine screening measure in the survivor population. To validate the CASS against the SCL-90-R screening measure. Calculate the sensitivity,specificity, positive and negative predictive values, diagnostic agreement and ROC curve of the CASS compared to the SCL-90. Determine the optimal cut-off scores to optimize agreement between the CASS and the SCL-90.
Study design
- Observational model
- Case only
- Time perspective
- Prospective
Who may qualify
- Ages
- 18 to 49 years
- Sex
- All
- Healthy volunteers
- Not accepted
- Age groups
- Adult
- Study population
- adult survivors of childhood cancer
Key inclusion criteria (6 listed)
- Currently at least 18 years of age and not older than 49 years of age
- Diagnosed with first malignancy before the age of 22
- Completed all cancer treatment at least three years prior
- Able to complete the survey instruments in English
- Scheduled for a routine off-treatment follow-up oncology appointment
Key exclusion criteria (3 listed)
- History of a central nervous system tumor
- A sensory or cognitive impairment that would interfere with completion of the survey
- Currently undergoing treatment by a psychiatrist or psychologist (ie., currently receiving psychotherapy and/or psychotropic medications, as per self-report)
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Primary outcome
Not reported in the source record.
Results and safety
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 28 Jul 2008.
- Memorial Sloan-Kettering Cancer CenterLink provided by the sponsor.
Related trials for Childhood Cancer
Recruiting
An Exploratory Study to Evaluate Immune Determinants of the Response to Adoptive Cell Therapy (ACT) in Solid and Hematologic Tumors
Solid Tumor, Adult, Solid Tumor, Childhood
Not yet recruiting
Pilot Testing ACCOMPANI: A Nurse-Targeted Intervention to Promote Psychosocial Equity in Pediatric Oncology
Pediatric Oncology, Childhood Cancers
Recruiting
COMUNICAR: Community-Led Family-Centered Communication for Cancer Survivorship Care
Childhood Cancer
Not yet recruiting
Multi-level Intervention to Successfully Transition to Adult Care for Survivors of Childhood and Adolescent Cancers: The BRIDGES-YAS! Study
Health Care Transition, Survivorship Care
Recruiting
Preparing for Life and Academics for Young Childhood Cancer Survivors
Childhood Cancer
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part. This study is not recruiting at the moment.
Jennifer Ford, PhD principal investigator
Memorial Sloan Kettering Cancer Center
1 site in 1 country: see every site and its status.
Questions about this trial
What is this clinical trial studying?
An observational study of Childhood Cancer, run by Memorial Sloan Kettering Cancer Center at 1 site in United States.
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 6 inclusion and 3 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: finished, as of the sponsor's last update on 28 Jul 2008. Status can change between updates, so confirm with the study contact before making plans.
Where is the study taking place?
The record lists 1 site in United States. Whether a site is taking part right now should be confirmed with that site. See every site.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
How can a doctor refer a patient or contact the research team?
The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.
Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 28 Jul 2008; AzTrials last refreshed its copy on 7 Nov 2026.